
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1152 | 1152 | 1082 | 799 | 976 | - |
Fund Return | 15.2% | 15.2% | 8.19% | -7.23% | -0.48% | - |
Place in category | 40 | 40 | 42 | 47 | 22 | - |
% in Category | 20 | 20 | 23 | 37 | 47 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
China Universal Consumer Industries | 11.54B | 0.76 | -7.53 | 7.88 | ||
China Universal Selective Mixed Sec | 8.97B | 1.97 | -6.33 | 5.52 | ||
China Universal Blue Chip Equity Fu | 4.28B | -0.73 | -6.77 | 6.11 | ||
China Universal Waiyan Gr Theme Eq | 3.47B | -0.65 | 0.52 | 1.64 | ||
China Univ Gr Factor Quant Strat Eq | 3.29B | 1.18 | 2.85 | 6.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid C | 32.09B | 2.17 | -16.08 | - | ||
Zhongou Medical and Health Hybrid A | 32.09B | 2.37 | -15.41 | - | ||
E Healthcare Secotor | 5.01B | 8.80 | 2.68 | 6.77 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 15.01 | 0.22 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 27.82 | 2.83 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 10.25 | 48.38 | -0.25% | |
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 8.91 | 47.45 | +9.99% | |
Kelun Pharm A | CNE100000PW7 | 8.47 | 35.68 | +3.27% | |
Sichuan Biokin Pharmaceutical | CNE100006FN4 | 7.62 | 244.20 | +1.52% | |
Salubris Pharm A | CNE100000FW8 | 6.12 | 33.34 | +3.57% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review